Profound Medical

Profound Medical

Health Care Equipment & Supplies
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

$252.1M

Market Cap • 10/9/2026

2014

(12 years)

Founded

2016

(10 years ago)

IPO

NASDAQ

Listing Exchange

Flag of Canada

Canada

Country

Valuation

P/B

5,1

P/S

13,2

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

1,4

EPS

—

Market Cap

Market Cap

252,1M

EV

221,2M

EV/Revenue

11,6

EV/EBITDA

-6,3

EV/EBIT

-6,3

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-304,3M

Profitability

Gross Margin

71,8%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

108%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

—

% PPE

5,3%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

17,7%

CAGR Op. Income 5Y

18,1%

CAGR Net Income 5Y

3,1%

CAGR EPS 5Y

-8,3%

CAGR OCF 5Y

22,2%

Leverage

N.D./EBITDA

0,9

Debt/Equity

0%

Current Ratio

6,5

Quick Ratio

5,3

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium